'MOLTO', A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON VENETOCLAX, ATEZOLIZUMAB, OBINUTUZUMAB (AVO) COMBINATION IN RICHTER TRANSFORMATION: SAFETY INTERIM ANALYSIS

Authors :: Frustaci, AM
Tedeschi, A
Zinzani, PL
Pietrasanta, D
Coscia, M
Zenz, T
Motta, M
Gaidano, G
Scarfo, L
Deodato, M
Zamprogna, G
Vitale, C
Cairoli, R
Rossi, D
Montillo, M
Frustaci, A
Tedeschi, A
Zinzani, P
Pietrasanta, D
Coscia, M
Zenz, T
Motta, M
Gaidano, G
Scarfo, L
Deodato, M
Zamprogna, G
Vitale, C
Cairoli, R
Rossi, D
Montillo, M
Publication Year :: 2021
Publisher :: FERRATA STORTI FOUNDATION, 2021.

Tools